Valuation Pacific Biosciences of California, Inc.
Stocks
PACB
US69404D1081
Advanced Medical Equipment & Technology
|
Market Closed -
Nasdaq
23:00:00 30/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 2.605 USD | -10.17% |
|
+23.46% | +39.30% |
Company Valuation: Pacific Biosciences of California, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 4,513 | 1,850 | 2,624 | 538.6 | 564.6 | 809.7 | - | - |
| Change | - | -59.02% | 41.85% | -79.47% | 4.82% | 43.42% | - | - |
| Enterprise Value (EV) 1 | 4,365 | 1,974 | 2,884 | 796.2 | 930.4 | 1,279 | 1,336 | 1,367 |
| Change | - | -54.78% | 46.13% | -72.4% | 16.87% | 37.42% | 4.51% | 2.34% |
| P/E | -23x | -5.84x | -8.11x | -1.63x | -1.03x | -5.85x | -5.66x | -7.24x |
| PBR | 5.72x | 3.29x | 3.75x | 1.06x | 106x | -9.42x | -5.11x | -3.92x |
| PEG | - | -0.1x | 0.6x | 0.22x | -0x | 0.1x | -1.68x | 0.3x |
| Capitalization / Revenue | 34.6x | 14.4x | 13.1x | 3.5x | 3.53x | 5.1x | 4.4x | 3.84x |
| EV / Revenue | 33.4x | 15.4x | 14.4x | 5.17x | 5.82x | 8.06x | 7.26x | 6.48x |
| EV / EBITDA | -21.5x | -6.65x | -9.16x | -1.84x | -6.09x | -9.79x | -10.6x | -13.1x |
| EV / EBIT | -20.7x | -6.43x | -8.62x | -1.68x | -1.68x | -9.21x | -8.97x | -10.7x |
| EV / FCF | -37.3x | -7.05x | -10.8x | -3.75x | -8.17x | -10x | -14.6x | -24.1x |
| FCF Yield | -2.68% | -14.2% | -9.29% | -26.7% | -12.2% | -9.97% | -6.86% | -4.15% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.89 | -1.4 | -1.21 | -1.12 | -1.82 | -0.445 | -0.46 | -0.36 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 130.5 | 128.3 | 200.5 | 154 | 160 | 158.7 | 184.1 | 211 |
| EBITDA 1 | -202.9 | -296.8 | -314.7 | -431.9 | -152.7 | -130.5 | -125.5 | -104.7 |
| EBIT 1 | -210.4 | -307.2 | -334.5 | -473.1 | -553.9 | -138.9 | -149 | -128.1 |
| Net income 1 | -181.2 | -314.2 | -306.7 | -308.7 | -546.4 | -138 | -147.1 | -126.8 |
| Net Debt 1 | -148.3 | 124.4 | 260.8 | 257.6 | 365.9 | 468.9 | 526.6 | 557.8 |
| Reference price 2 | 20.460 | 8.180 | 9.810 | 1.830 | 1.870 | 2.605 | 2.605 | 2.605 |
| Nbr of stocks (in thousands) | 220,598 | 226,109 | 267,444 | 294,315 | 301,907 | 310,831 | - | - |
| Announcement Date | 2/15/22 A | 2/16/23 A | 2/15/24 A | 2/13/25 A | 2/12/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.85x | 8.06x | -9.79x | - | 810M | |
| 35.69x | 6.07x | 23.2x | 0.27% | 258B | |
| 36.92x | 7x | 21.93x | 0.62% | 163B | |
| 49.76x | 12.05x | 25.86x | -.--% | 150B | |
| 17x | 3.45x | 11.22x | -.--% | 60.84B | |
| 36.47x | 7.31x | 23.11x | -.--% | 53.03B | |
| 21x | 2.51x | 12.66x | 2.4% | 53.31B | |
| 34.07x | 6.75x | 22.92x | 0.59% | 49.3B | |
| 47.92x | 11.82x | 26.05x | -.--% | 50.67B | |
| 81x | 7.7x | 23.37x | -.--% | 45.46B | |
| Average | 35.40x | 7.27x | 18.05x | 0.43% | 88.43B | |
| Weighted average by Cap. | 39.08x | 7.39x | 22.08x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PACB Stock
- Valuation Pacific Biosciences of California, Inc.
Select your edition
All financial news and data tailored to specific country editions
